by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi
by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi
by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe
by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe
by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa
by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
byNIH/National Human Genome Research InstituteNIH researchers and collaborators have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of
byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
The World Health Organization (WHO) has recently updated its list of priority pathogens, identifying over 30 viruses and bacteria that have the potential to cause the next global health crisis.
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
Announcement of the 2024 Nobel Prize in ChemistryThe Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was...Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine...AlphaFold: The making of a scientific breakthroughThe inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p...